Support By : Li-lab
PATHWAY_NAME | REACTOME_ID | KEGG_ID | DRUG_NAME | PUBCHEM_CID | Datasource |
---|---|---|---|---|---|
Huntington's disease | R-HSA-1643685 | 0 | verapamil | 2520 | drug-path |
Cytokine-cytokine receptor interaction | R-HSA-6788467 | map04060 | verapamil | 2520 | drug-path |
Ubiquitin mediated proteolysis | R-HSA-983153 | map04120 | rofecoxib | 5090 | drug-path |
Huntington's disease | R-HSA-1643685 | 0 | rofecoxib | 5090 | drug-path |
Olfactory transduction | R-HSA-9751605 | map04740 | rofecoxib | 5090 | drug-path |
Systemic lupus erythematosus | R-HSA-977105 | map05322 | rofecoxib | 5090 | drug-path |
Jak-STAT signaling pathway | R-HSA-168638 | map04630 | rofecoxib | 5090 | drug-path |
Regulation of actin cytoskeleton | R-HSA-392751 | map04810 | rofecoxib | 5090 | drug-path |
Parkinson's disease | R-HSA-1643685 | 0 | rofecoxib | 5090 | drug-path |
Vibrio cholerae infection | R-HSA-9609646 | map05110 | rofecoxib | 5090 | drug-path |
Cardiac muscle contraction | R-HSA-397014 | map04260 | rofecoxib | 5090 | drug-path |
Ribosome | R-HSA-5368277 | map03010 | rofecoxib | 5090 | drug-path |
Adherens junction | R-HSA-451386 | map04520 | exemestane | 60198 | drug-path |
Alzheimer's disease | R-HSA-1643685 | 0 | sulindac | 1548887 | drug-path |
Autoimmune thyroid disease | R-HSA-1643685 | map05320 | sulindac | 1548887 | drug-path |
Antigen processing and presentation | R-HSA-1236975 | map04612 | sulindac | 1548887 | drug-path |
Olfactory transduction | R-HSA-9751605 | map04740 | sulindac | 1548887 | drug-path |
Systemic lupus erythematosus | R-HSA-977105 | map05322 | sulindac | 1548887 | drug-path |
Asthma | R-HSA-444620 | map05310 | sulindac | 1548887 | drug-path |
Parkinson's disease | R-HSA-1643685 | 0 | sulindac | 1548887 | drug-path |